With imatinib treatment and ABL-edited virus infection of K562-IR cells, we found that K562-IR cells with the ABL sgRNA_2 virus showed significant cancer cell growth inhibition (Figure 7F, p < 0.05), which was even higher than that with the high concentration (25 μM) of imatinib. Here, ABL1 is linked to viral infectious disease.